Achieve Life Sciences appoints Nancy Phelan and Kristen Slaoui to board; Himes resigns

ACHIEVE LIFE SCIENCES, INC.

Dr. Vaughn Himes resigned from board effective Jan 6, 2025; no disagreement; will continue consulting.
Board appointed Nancy R. Phelan and Kristen B. Slaoui, Ph.D. as directors, effective Jan 6, 2025.
Each new director receives $40,000 annual retainer for FY2025 and stock option for 47,250 shares (3-yr vest).
Additionally, annual equity option for 31,500 shares vesting over one year, subject to continued service.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kristen B. Slaoui

Director

ACHV · ACHIEVE LIFE SCIENCES, INC.

Effective: 2025-01-06
Filed: January 10, 2025, 6:59 PM ET

On January 6, 2025, the Board appointed each of Nancy R. Phelan and Kristen B. Slaoui, Ph.D. (together, the “Incoming Directors”) to serve as a director of the Company, effective January 6, 2025.

Departed

Vaughn Himes

Director

ACHV · ACHIEVE LIFE SCIENCES, INC.

Effective: 2025-01-06
Filed: January 10, 2025, 6:59 PM ET

On January 6, 2025, Dr. Vaughn Himes informed the board of directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”), that he has elected to resign from his position as a member of the Board, effective immediately.

Appointed

Nancy R. Phelan

Director

ACHV · ACHIEVE LIFE SCIENCES, INC.

Effective: 2025-01-06
Filed: January 10, 2025, 6:59 PM ET

On January 6, 2025, the Board appointed each of Nancy R. Phelan and Kristen B. Slaoui, Ph.D. (together, the “Incoming Directors”) to serve as a director of the Company, effective January 6, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kristen B. Slaoui was appointed as Director at ACHIEVE LIFE SCIENCES, INC..

Action: appointed
Role: Director

Exact text from the filing

On January 6, 2025, the Board appointed each of Nancy R. Phelan and Kristen B. Slaoui, Ph.D. (together, the “Incoming Directors”) to serve as a director of the Company, effective January 6, 2025.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Vaughn Himes resigned as Director at ACHIEVE LIFE SCIENCES, INC..

Action: resigned
Role: Director

Exact text from the filing

On January 6, 2025, Dr. Vaughn Himes informed the board of directors (the “Board”) of Achieve Life Sciences, Inc. (the “Company”), that he has elected to resign from his position as a member of the Board, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Nancy R. Phelan was appointed as Director at ACHIEVE LIFE SCIENCES, INC..

Action: appointed
Role: Director

Exact text from the filing

On January 6, 2025, the Board appointed each of Nancy R. Phelan and Kristen B. Slaoui, Ph.D. (together, the “Incoming Directors”) to serve as a director of the Company, effective January 6, 2025.

View on SEC.gov

ACHIEVE LIFE SCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0000950170-25-003873

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.